|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Htg Molecular Diagnostics, Inc (HTGM) |
|
|
$0.28 0.00 (0.00%) as of 4:30 Fri 11/20
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
9,000,000 |
| Market
Cap: |
2.56(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2849 - $0.2849 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile HTG Molecular Diagnostics is a commercial stage RNA platform-based life sciences company focused on developing medicine. Co.'s product and service solutions are based on its digital HTG EdgeSeq technology that enables RNA profiling using a small amount of biological sample, in liquid or solid forms. Co. markets proprietary molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. Co.'s marketed panels include: HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq Precision Immuno-Oncology Panel; HTG Lung Fusions Assay; HTG Autoimmune Panel; HTG EdgeSeq Immuno-Oncology Assay; and HTG Mouse mRNA Tumor Response Panel.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
888 |
888 |
| Total Sell Value |
$0 |
$0 |
$710 |
$710 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Barat Stephen |
Senior VP of Therapeutics |
• – – |
2023-06-08 |
4 |
S |
$0.80 |
$710 |
D/D |
(888) |
421 |
|
- |
|
| Barat Stephen |
Senior VP of Therapeutics |
• – – |
2023-03-31 |
4 |
D |
$2.70 |
$140 |
D/D |
(52) |
1,309 |
|
- |
|
| Barat Stephen |
Senior VP of TherapeuticsOffic |
• – – |
2023-02-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,361 |
|
- |
|
| Lubniewski John L |
President & CEO |
• • – |
2022-12-09 |
4 |
A |
$0.43 |
$425 |
D/D |
1,000 |
14,133 |
|
- |
|
| Godlewski Laura Lee |
SVP Finance & Administration |
• – – |
2022-12-09 |
4 |
A |
$0.43 |
$425 |
D/D |
1,000 |
4,904 |
|
- |
|
| Lawson Byron |
SVP/Chief Commercial Officer |
• – – |
2022-12-09 |
4 |
A |
$0.43 |
$425 |
D/D |
1,000 |
6,033 |
|
- |
|
| Mcmeans Shaun D |
SVP, Finance & Admin. & CFO |
• – – |
2022-12-09 |
4 |
A |
$0.43 |
$425 |
D/D |
1,000 |
10,570 |
|
- |
|
| L5 Capital Inc. |
10% Owner |
– – • |
2022-07-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,170,000 |
|
- |
|
| Mcmeans Shaun D |
SVP, Finance & Admin. & CFO |
• – – |
2022-06-30 |
4 |
D |
$1.03 |
$30 |
D/D |
(29) |
9,570 |
|
- |
|
| Lubniewski John L |
President & CEO |
• • – |
2022-06-30 |
4 |
D |
$1.03 |
$63 |
D/D |
(61) |
13,133 |
|
- |
|
| Lawson Byron |
SVP/Chief Commercial Officer |
• – – |
2022-06-30 |
4 |
D |
$1.03 |
$24 |
D/D |
(23) |
5,033 |
|
- |
|
| Lubniewski John L |
President & CEO |
• • – |
2022-06-10 |
4 |
A |
$0.48 |
$476 |
D/D |
1,000 |
13,194 |
|
- |
|
| Lawson Byron |
SVP/Chief Commercial Officer |
• – – |
2022-06-10 |
4 |
A |
$0.48 |
$476 |
D/D |
1,000 |
5,056 |
|
- |
|
| Godlewski Laura Lee |
SVP Finance & Administration |
• – – |
2022-06-10 |
4 |
A |
$0.48 |
$476 |
D/D |
1,000 |
3,904 |
|
- |
|
| Mcmeans Shaun D |
SVP, Finance & Admin. & CFO |
• – – |
2022-06-10 |
4 |
A |
$0.48 |
$476 |
D/D |
1,000 |
9,599 |
|
- |
|
| Mcmeans Shaun D |
SVP, Finance & Admin. & CFO |
• – – |
2022-03-31 |
4 |
D |
$1.39 |
$43 |
D/D |
(31) |
8,599 |
|
- |
|
| Lubniewski John L |
President & CEO |
• • – |
2022-03-31 |
4 |
D |
$1.39 |
$86 |
D/D |
(62) |
12,194 |
|
- |
|
| Lawson Byron |
SVP/Chief Commercial Officer |
• – – |
2022-03-31 |
4 |
D |
$1.39 |
$32 |
D/D |
(23) |
4,056 |
|
- |
|
| Lawson Byron |
SVP/Chief Commercial Officer |
• – – |
2021-12-31 |
4 |
D |
$5.42 |
$130 |
D/D |
(24) |
4,079 |
|
- |
|
| Lubniewski John L |
President & CEO |
• • – |
2021-12-31 |
4 |
D |
$5.42 |
$336 |
D/D |
(62) |
12,256 |
|
- |
|
| Mcmeans Shaun D |
SVP, Finance & Admin. & CFO |
• – – |
2021-12-31 |
4 |
D |
$5.42 |
$168 |
D/D |
(31) |
8,630 |
|
- |
|
| Lawson Byron |
SVP/Chief Commercial Officer |
• – – |
2021-12-10 |
4 |
A |
$3.56 |
$3,191 |
D/D |
896 |
4,103 |
|
- |
|
| Godlewski Laura Lee |
VP Finance, Prin Acct Offr |
• – – |
2021-12-10 |
4 |
A |
$3.56 |
$3,562 |
D/D |
1,000 |
2,904 |
|
- |
|
| Lubniewski John L |
President & CEO |
• • – |
2021-12-10 |
4 |
A |
$3.56 |
$3,562 |
D/D |
1,000 |
12,318 |
|
- |
|
| Mcmeans Shaun D |
SVP, Finance & Admin. & CFO |
• – – |
2021-12-10 |
4 |
A |
$3.56 |
$1,852 |
D/D |
520 |
8,661 |
|
- |
|
227 Records found
|
|
Page 1 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
